Fig. 1From: Intravoxel incoherent motion MRI as a biomarker of sorafenib treatment for advanced hepatocellular carcinoma: a pilot studyApparent diffusion coefficients (ADCs) of the responders and non-responders at baseline, and after 1, 2, and 4 weeks of sorafenib treatment. At baseline, ADC values in the responder group were higher than those in the non-responder group; however, the difference was not statistically significantBack to article page